Selected research
Industry Research
Ketorolac Injection Industry Research Report 2026
Market perspective
The global Ketorolac Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Ketorolac Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Ketorolac Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Ketorolac Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Ketorolac Injection include Pfizer, Fresenius Kabi, Fosun Pharma (Gland Pharma), Sagent Pharmaceuticals, Hikma, Lunan Pharma, Alvogen, Chengdu Brilliant Pharmaceuticals and Athenex, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Ketorolac Injection market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Ketorolac Injection Market by Company
Pfizer
Fresenius Kabi
Fosun Pharma (Gland Pharma)
Sagent Pharmaceuticals
Hikma
Lunan Pharma
Alvogen
Chengdu Brilliant Pharmaceuticals
Athenex
Sichuan Medcalo
Julphar Bangladesh Ltd.
Yung Shin Pharm
Tianjin Chase Sun Pharmaceutical
ZISKA Pharmaceuticals
Ketorolac Injection Segment by Concentration
15mg/ml
30mg/ml
Ketorolac Injection Segment by Application
Hospital
Clinics
Others
Ketorolac Injection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ketorolac Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ketorolac Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ketorolac Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Ketorolac Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Ketorolac Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Ketorolac Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by concentration, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 15mg/ml
- 30mg/ml
Applications
- Hospital
- Clinics
- Others
Companies covered
- Pfizer
- Fresenius Kabi
- Fosun Pharma (Gland Pharma)
- Sagent Pharmaceuticals
- Hikma
- Lunan Pharma
- Alvogen
- Chengdu Brilliant Pharmaceuticals
- Athenex
- Sichuan Medcalo
- Julphar Bangladesh Ltd.
- Yung Shin Pharm
- Tianjin Chase Sun Pharmaceutical
- ZISKA Pharmaceuticals
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Ketorolac Injection Market Size (2021-2032)
- 2.2.2 Global Ketorolac Injection Sales (2021-2032)
- 2.2.3 Global Ketorolac Injection Market Average Price (2021-2032)
- 2.3 Ketorolac Injection by Concentration
- 2.3.1 Market Value Comparison by Concentration (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 15mg/ml
- 2.3.3 30mg/ml
- 2.4 Ketorolac Injection by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinics
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Ketorolac Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Ketorolac Injection Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Ketorolac Injection Revenue of Manufacturers (2021-2026)
- 3.4 Global Ketorolac Injection Average Price by Manufacturers (2021-2026)
- 3.5 Global Ketorolac Injection Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Ketorolac Injection, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Ketorolac Injection, Product Type & Application
- 3.8 Global Manufacturers of Ketorolac Injection, Established Date
- 3.9 Global Ketorolac Injection Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Pfizer
- 4.1.1 Pfizer Company Information
- 4.1.2 Pfizer Business Overview
- 4.1.3 Pfizer Ketorolac Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Pfizer Ketorolac Injection Product Portfolio
- 4.1.5 Pfizer Recent Developments
- 4.2 Fresenius Kabi
- 4.2.1 Fresenius Kabi Company Information
- 4.2.2 Fresenius Kabi Business Overview
- 4.2.3 Fresenius Kabi Ketorolac Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Fresenius Kabi Ketorolac Injection Product Portfolio
- 4.2.5 Fresenius Kabi Recent Developments
- 4.3 Fosun Pharma (Gland Pharma)
- 4.3.1 Fosun Pharma (Gland Pharma) Company Information
- 4.3.2 Fosun Pharma (Gland Pharma) Business Overview
- 4.3.3 Fosun Pharma (Gland Pharma) Ketorolac Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Fosun Pharma (Gland Pharma) Ketorolac Injection Product Portfolio
- 4.3.5 Fosun Pharma (Gland Pharma) Recent Developments
- 4.4 Sagent Pharmaceuticals
- 4.4.1 Sagent Pharmaceuticals Company Information
- 4.4.2 Sagent Pharmaceuticals Business Overview
- 4.4.3 Sagent Pharmaceuticals Ketorolac Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Sagent Pharmaceuticals Ketorolac Injection Product Portfolio
- 4.4.5 Sagent Pharmaceuticals Recent Developments
- 4.5 Hikma
- 4.5.1 Hikma Company Information
- 4.5.2 Hikma Business Overview
- 4.5.3 Hikma Ketorolac Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Hikma Ketorolac Injection Product Portfolio
- 4.5.5 Hikma Recent Developments
- 4.6 Lunan Pharma
- 4.6.1 Lunan Pharma Company Information
- 4.6.2 Lunan Pharma Business Overview
- 4.6.3 Lunan Pharma Ketorolac Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Lunan Pharma Ketorolac Injection Product Portfolio
- 4.6.5 Lunan Pharma Recent Developments
- 4.7 Alvogen
- 4.7.1 Alvogen Company Information
- 4.7.2 Alvogen Business Overview
- 4.7.3 Alvogen Ketorolac Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Alvogen Ketorolac Injection Product Portfolio
- 4.7.5 Alvogen Recent Developments
- 4.8 Chengdu Brilliant Pharmaceuticals
- 4.8.1 Chengdu Brilliant Pharmaceuticals Company Information
- 4.8.2 Chengdu Brilliant Pharmaceuticals Business Overview
- 4.8.3 Chengdu Brilliant Pharmaceuticals Ketorolac Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Chengdu Brilliant Pharmaceuticals Ketorolac Injection Product Portfolio
- 4.8.5 Chengdu Brilliant Pharmaceuticals Recent Developments
- 4.9 Athenex
- 4.9.1 Athenex Company Information
- 4.9.2 Athenex Business Overview
- 4.9.3 Athenex Ketorolac Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Athenex Ketorolac Injection Product Portfolio
- 4.9.5 Athenex Recent Developments
- 4.10 Sichuan Medcalo
- 4.10.1 Sichuan Medcalo Company Information
- 4.10.2 Sichuan Medcalo Business Overview
- 4.10.3 Sichuan Medcalo Ketorolac Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Sichuan Medcalo Ketorolac Injection Product Portfolio
- 4.10.5 Sichuan Medcalo Recent Developments
- 4.11 Julphar Bangladesh Ltd.
- 4.11.1 Julphar Bangladesh Ltd. Company Information
- 4.11.2 Julphar Bangladesh Ltd. Business Overview
- 4.11.3 Julphar Bangladesh Ltd. Ketorolac Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Julphar Bangladesh Ltd. Ketorolac Injection Product Portfolio
- 4.11.5 Julphar Bangladesh Ltd. Recent Developments
- 4.12 Yung Shin Pharm
- 4.12.1 Yung Shin Pharm Company Information
- 4.12.2 Yung Shin Pharm Business Overview
- 4.12.3 Yung Shin Pharm Ketorolac Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Yung Shin Pharm Ketorolac Injection Product Portfolio
- 4.12.5 Yung Shin Pharm Recent Developments
- 4.13 Tianjin Chase Sun Pharmaceutical
- 4.13.1 Tianjin Chase Sun Pharmaceutical Company Information
- 4.13.2 Tianjin Chase Sun Pharmaceutical Business Overview
- 4.13.3 Tianjin Chase Sun Pharmaceutical Ketorolac Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Tianjin Chase Sun Pharmaceutical Ketorolac Injection Product Portfolio
- 4.13.5 Tianjin Chase Sun Pharmaceutical Recent Developments
- 4.14 ZISKA Pharmaceuticals
- 4.14.1 ZISKA Pharmaceuticals Company Information
- 4.14.2 ZISKA Pharmaceuticals Business Overview
- 4.14.3 ZISKA Pharmaceuticals Ketorolac Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 ZISKA Pharmaceuticals Ketorolac Injection Product Portfolio
- 4.14.5 ZISKA Pharmaceuticals Recent Developments
5 Global Ketorolac Injection Market Scenario by Region
- 5.1 Global Ketorolac Injection Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Ketorolac Injection Sales by Region: 2021-2032
- 5.2.1 Global Ketorolac Injection Sales by Region: 2021-2026
- 5.2.2 Global Ketorolac Injection Sales by Region: 2027-2032
- 5.3 Global Ketorolac Injection Revenue by Region: 2021-2032
- 5.3.1 Global Ketorolac Injection Revenue by Region: 2021-2026
- 5.3.2 Global Ketorolac Injection Revenue by Region: 2027-2032
- 5.4 North America Ketorolac Injection Market Facts & Figures by Country
- 5.4.1 North America Ketorolac Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Ketorolac Injection Sales by Country (2021-2032)
- 5.4.3 North America Ketorolac Injection Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Ketorolac Injection Market Facts & Figures by Country
- 5.5.1 Europe Ketorolac Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Ketorolac Injection Sales by Country (2021-2032)
- 5.5.3 Europe Ketorolac Injection Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Ketorolac Injection Market Facts & Figures by Country
- 5.6.1 Asia Pacific Ketorolac Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Ketorolac Injection Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Ketorolac Injection Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Ketorolac Injection Market Facts & Figures by Country
- 5.7.1 South America Ketorolac Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Ketorolac Injection Sales by Country (2021-2032)
- 5.7.3 South America Ketorolac Injection Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Ketorolac Injection Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Ketorolac Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Ketorolac Injection Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Ketorolac Injection Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Concentration
- 6.1 Global Ketorolac Injection Sales by Concentration (2021-2032)
- 6.1.1 Global Ketorolac Injection Sales by Concentration (2021-2032) & (K Units)
- 6.1.2 Global Ketorolac Injection Sales Market Share by Concentration (2021-2032)
- 6.2 Global Ketorolac Injection Revenue by Concentration (2021-2032)
- 6.2.1 Global Ketorolac Injection Sales by Concentration (2021-2032) & (US$ Million)
- 6.2.2 Global Ketorolac Injection Revenue Market Share by Concentration (2021-2032)
- 6.3 Global Ketorolac Injection Price by Concentration (2021-2032)
7 Segment by Application
- 7.1 Global Ketorolac Injection Sales by Application (2021-2032)
- 7.1.1 Global Ketorolac Injection Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Ketorolac Injection Sales Market Share by Application (2021-2032)
- 7.2 Global Ketorolac Injection Revenue by Application (2021-2032)
- 7.2.1 Global Ketorolac Injection Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Ketorolac Injection Revenue Market Share by Application (2021-2032)
- 7.3 Global Ketorolac Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Ketorolac Injection Value Chain Analysis
- 8.1.1 Ketorolac Injection Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Ketorolac Injection Production Mode & Process
- 8.2 Ketorolac Injection Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Ketorolac Injection Distributors
- 8.2.3 Ketorolac Injection Customers
9 Global Ketorolac Injection Analyzing Market Dynamics
- 9.1 Ketorolac Injection Industry Trends
- 9.2 Ketorolac Injection Industry Drivers
- 9.3 Ketorolac Injection Industry Opportunities and Challenges
- 9.4 Ketorolac Injection Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst